Pier Luigi Zinzani et al.
Cancer, 116(20), 4788-4792 (2010-07-03)
Historically, the first treatment choices for hairy cell leukemia (HCL) were splenectomy and alpha-interferon. Recently, purine analogues (pentostatin and cladribine) changed radically the treatment modality, inducing complete and durable responses in the majority of patients. The authors analyzed the outcome